透過您的圖書館登入
IP:18.117.171.8
  • 期刊
  • OpenAccess

The antiviral and coronavirus-host protein pathways inhibiting properties of herbs and natural compounds - Additional weapons in the fight against the COVID-19 pandemic?

摘要


Introduction: As of March 11th, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. Articles published after the SARS-CoV-1 (2002) epidemic suggest that the use of an herbal-drug integrative medical approach could have contributed to a lower fatality rate and a more rapid response in controlling the outbreak. Methods: Pubmed was searched for articles that investigated the antiviral properties and mechanisms of action of herbs or natural compounds against the SARS-coronavirus (CoV). Results: Forty-three (43) relevant papers were located. A general count rendered 450þ herbs and natural compounds with antiviral properties against the SARS-CoV and related viruses. From the 43 articles, thirty-one (31) uncovered the mechanisms of action of the natural substances able to oppose the coronavirus. Discussion: A series of herbs and natural compounds demonstrated moderate to strong antiviral activity. Research on many herbs-natural compounds also showed potent and significant inhibition of CoV-host protein pathways responsible for different phases of viral replication specifically targeting 3CL^(PRO), PL^(PRO), RdRp, helicase protein, S protein, N protein, 3a protein, Cathepsin L, Nsp1, Nsp3c, and ORF7a, and the S protein/ACE-2 interaction. Conclusion: The herbs-natural compounds with antiviral activity and that caused inhibition/blockade of the CoV-host protein pathways are potential therapeutic candidates. The homology between the SARS-CoV- 1 and SARS-CoV-2 is around 80%. Thus, effective herbs-compounds for the former would likely be beneficial for the latter also depending on target protein similarities between the viruses. Here we provide the mechanistic bases supporting an integrative approach that includes natural compounds to fight coronavirus infections.

參考文獻


Yang Y, Islam M, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020;16(10):1708-1717. https://doi.org/10.7150/ijbs.45538. https://search.crossref.org/?q=+Yang+Y%2C+Islam+M%2C+Wang+J%2C+Li+Y%2C+Chen+X.+Traditional+Chinese+medicine+in+the+treatment+of+patients+infected+with+2019-new+coronavirus+%28SARS-CoV-2%29%3A+a+review+and+perspective
Schwarz S, Wang K, Yu W, Sun B, Schwarz W. Emodin inhibits current through SARS-associated coronavirus 3a protein. Antivir Res. 2011;90(1): 64-69. https://doi.org/10.1016/j.antiviral.2011.02.008
Wu C, Jan J, Ma S, et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proc Natl Acad Sci USA. 2004;101(27): 10012-10017. https://doi.org/10.1073/pnas.0403596101
Chen C, Lin C, Huang K, et al. Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3’-digallate (TF3). Evid Based Complement Altern Med. 2005;2(2):209-215. https://doi.org/10.1093/ecam/neh081
Chen L, Wang Y, Lin Y, et al. Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. Bioorg Med Chem Lett. 2005;15(12):3058-3062. https://doi.org/10.1016/j.bmcl.2005.04.027

被引用紀錄


Vardhan, S., & Sahoo, S. K. (2022). Exploring the therapeutic nature of limonoids and triterpenoids against SARS-CoV-2 by targeting nsp13, nsp14, and nsp15 through molecular docking and dynamics simulations. Journal of Traditional and Complementary Medicine, 12(1), 44-54. https://doi.org/10.1016/j.jtcme.2021.12.002
Vidoni, C., Fuzimoto, A., Ferraresi, A., & Isidoro, C. (2022). Targeting autophagy with natural products to prevent SARS-CoV-2 infection. Journal of Traditional and Complementary Medicine, 12(1), 55-68. https://doi.org/10.1016/j.jtcme.2021.10.003
Singh, R., Bhardwaj, V. K., Sharma, J., Purohit, R., & Kumar, S. (2022). In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors. Journal of Traditional and Complementary Medicine, 12(1), 35-43. https://doi.org/10.1016/j.jtcme.2021.05.005
Zaki, A. A., Ashour, A., Elhady, S. S., Darwish, K. M., & Karmalawy, A. A. A. (2022). Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies. Journal of Traditional and Complementary Medicine, 12(1), 16-34. https://doi.org/10.1016/j.jtcme.2021.05.001
Vardhan, S., & Sahoo, S. K. (2022). Virtual screening by targeting proteolytic sites of furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. Journal of Traditional and Complementary Medicine, 12(1), 6-15. https://doi.org/10.1016/j.jtcme.2021.04.001

延伸閱讀